Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Atopic Dermatitis Patients Treated With Dupilumab in Taiwan

NCT05442645 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05442645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Atopic Dermatitis Patients Treated With Dupilumab in Taiwan
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
July 20, 2022
Completion date
June 18, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis